New Australian research has identified that over half of the risk factors related to developing MS are environmental factors, meaning that they can be altered through lifestyle or other changes.read more
Vitamin D is mainly synthesised in the skin in response to ultraviolet radiation, with a smaller proportion of our daily vitamin D requirements coming from our diet. It plays a…read more
Most disease modifying therapies used to treat MS are not recommended for use during pregnancy or in those who are planning a pregnancy and clinical studies for pregnant women are…read more
A recent collaboration between MS neurologists has brought together the latest information on treatments and best practice for MS care.read more
Researchers from the Royal Melbourne Hospital and the University of Melbourne this week published new findings that could change the way doctors identify MS lesions using brain scanning.read more
Bladder or bowel symptoms commonly occur in MS. The symptoms, including incontinence from the bladder or bowel, can have a profound effect upon an individual’s quality of life and self-esteem.…read more
There are now over 110 genetic changes that are known to increase an individual’s susceptibility to MS.read more
Fatigue is a common problem for many people with MS, and some people with MS can also experience mental health issues such as anxiety and stress. Each of these issues…read more
The New Zealand Multiple Sclerosis Research Trust (“NZMSRT”) today announces it has received a combined $900,000 investment portfolio as founding capital for the Trust.read more
Neil Woodhams had no experience of the incurable neurological disease multiple sclerosis (MS) until his wife Erin was diagnosed with it in 1994. There was little reliable information, limited drugs…read more
Two articles published recently by Australian and international investigators using the MSBase database provide insight into several factors that most strongly predict the risk of accumulating MS-related disability.read more
An Australian research team led by Professor Claude Bernard and Dr Natalie Payne, working with colleagues at the Australian Regenerative Medicine Institute at Monash University in Victoria, have been investigating…read more
Over the last few years, genetic studies that included thousands of people with MS from around the world have identified a large number of genetic changes that may increase a…read more
Incidence studies are a well validated tool to better elucidate the cause and risk factors of a disease and plan effective preventive and management strategies. New Zealand (NZ) is ideally…read more
The pharmaceutical sponsor of Gilenya (fingolimod), Novartis, has this week reported one case of Progressive Multifocal Leukoencephalopathy (PML) in an individual currently being treated with Gilenya in Europeread more
Researchers from the University of Virginia in the USA recently discovered a new structure linking the central nervous system and the immune system that had previously been unreported in the…read more
A shorter treatment gap is better when switching from natalizumab (Tysabri) to fingolimod (Gilenya)read more
MS Research Australia produces a monthly newsletter....read more
